{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:12:46Z","timestamp":1791817966568,"version":"4.3.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T00:00:00Z","timestamp":1273536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00198-010-1272-8","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T14:31:33Z","timestamp":1273501893000},"page":"1-20","source":"Crossref","is-referenced-by-count":130,"title":["New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK\/RANKL axis"],"prefix":"10.1007","volume":"22","author":[{"given":"J. C.","family":"Crockett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Mellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. I.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,11]]},"reference":[{"key":"1272_CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum SL (2007) Osteoclasts: what do they do and how do they do it? Am J Pathol 170:427\u2013435","journal-title":"Am J Pathol"},{"key":"1272_CR2","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","volume":"190","author":"F Arai","year":"1999","unstructured":"Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190:1741\u20131754","journal-title":"J Exp Med"},{"key":"1272_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira dSA, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315\u201323","journal-title":"Nature"},{"key":"1272_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"1272_CR5","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"1272_CR6","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97:1566\u20131571","journal-title":"Proc Natl Acad Sci USA"},{"key":"1272_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"1272_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1196\/annals.1443.016","volume":"1143","author":"A Leibbrandt","year":"2008","unstructured":"Leibbrandt A, Penninger JM (2008) RANK\/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 1143:123\u2013150","journal-title":"Ann N Y Acad Sci"},{"key":"1272_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature08596","volume":"462","author":"R Hanada","year":"2009","unstructured":"Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, Trichereau J, Paolino M, Qadri F, Plehm R, Klaere S, Komnenovic V, Mimata H, Yoshimatsu H, Takahashi N, von HA, Bader M, Kilic SS, Ueta Y, Pifl C, Narumiya S, Penninger JM (2009) Central control of fever and female body temperature by RANKL\/RANK. Nature 462:505\u20139","journal-title":"Nature"},{"key":"1272_CR10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1126\/science.276.5310.270","volume":"276","author":"J Salo","year":"1997","unstructured":"Salo J, Lehenkari P, Mulari M, Metsikko K, V\u00e4\u00e4n\u00e4nen HK (1997) Removal of osteoclast bone resorption products by transcytosis. Science 276:270\u2013273","journal-title":"Science"},{"key":"1272_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.276.5310.266","volume":"276","author":"SA Nesbitt","year":"1997","unstructured":"Nesbitt SA, Horton MA (1997) Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276:266\u2013269","journal-title":"Science"},{"key":"1272_CR12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature06907","volume":"453","author":"AR Graves","year":"2008","unstructured":"Graves AR, Curran PK, Smith CL, Mindell JA (2008) The Cl-\/H+antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453:788\u2013792","journal-title":"Nature"},{"key":"1272_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","volume":"104","author":"U Kornak","year":"2001","unstructured":"Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ (2001) Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205\u2013215","journal-title":"Cell"},{"key":"1272_CR14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","volume":"273","author":"BD Gelb","year":"1996","unstructured":"Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236\u20131238","journal-title":"Science"},{"key":"1272_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans W, Patel N, Ebeling M, Van HE, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van HW (2002) Identification of a 52\u00a0kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91\u201397","journal-title":"J Med Genet"},{"key":"1272_CR16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/368277","volume":"72","author":"L Wesenbeeck Van","year":"2003","unstructured":"Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, B\u00e9nichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, de Vernejoul MC, Bollerslev J, Van HW (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763\u2013771","journal-title":"Am J Hum Genet"},{"key":"1272_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den EJ, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537\u2013543","journal-title":"Hum Mol Genet"},{"key":"1272_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","volume":"84","author":"A Villa","year":"2009","unstructured":"Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C (2009) Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int 84:1\u201312","journal-title":"Calcif Tissue Int"},{"key":"1272_CR19","first-page":"368","volume":"51","author":"HE Albers-Sch\u00f6nberg","year":"1904","unstructured":"Albers-Sch\u00f6nberg HE (1904) R\u00f6ntgenbilder einer seltener Knochenerkrankung. M\u00fcnch Med Wochenschr 51:368","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"1272_CR20","unstructured":"Marks SCJ, Walker DG (1976) Mammalian osteopetrosis. A model for studying cellular and humoral factors in bone resorption. 227-301"},{"key":"1272_CR21","unstructured":"Marks SC Jr (1984) Congenital osteopetrotic mutations as probes of the origin, structure, and function of osteoclasts. Clin Orthop:239-263"},{"key":"1272_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajmg.1320340110","volume":"34","author":"SC Marks Jr","year":"1989","unstructured":"Marks SC Jr (1989) Osteoclast biology: lessons from mammalian mutations. Am J Med Genet 34:43\u201354","journal-title":"Am J Med Genet"},{"key":"1272_CR23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.1198094","volume":"190","author":"DG Walker","year":"1975","unstructured":"Walker DG (1975) Spleen cells transmit osteopetrosis in mice. Science 190:785\u2013787","journal-title":"Science"},{"key":"1272_CR24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.1105786","volume":"190","author":"DG Walker","year":"1975","unstructured":"Walker DG (1975) Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 190:784\u2013785","journal-title":"Science"},{"key":"1272_CR25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.180.4088.875","volume":"180","author":"DG Walker","year":"1973","unstructured":"Walker DG (1973) Osteopetrosis cured by temporary parabiosis. Science 180:875","journal-title":"Science"},{"key":"1272_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1148\/radiology.157.2.2413500","volume":"157","author":"WA Cumming","year":"1985","unstructured":"Cumming WA, Ohlsson A (1985) Intracranial calcification in children with osteopetrosis caused by carbonic anhydrase II deficiency. Radiology 157:325\u2013327","journal-title":"Radiology"},{"key":"1272_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","volume":"26","author":"OD B\u00e9nichou","year":"2000","unstructured":"B\u00e9nichou OD, Laredo JD, de Vernejoul MC (2000) Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients. Bone 26:87\u201393","journal-title":"Bone"},{"key":"1272_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","volume":"43","author":"A Fattore Del","year":"2006","unstructured":"Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, Devito R, Pinto R, Caniglia M, Lanino E, Messina C, Cesaro S, Letizia C, Bianchini G, Fryssira H, Grabowski P, Shaw N, Bishop N, Hughes D, Kapur RP, Datta HK, Taranta A, Fornari R, Migliaccio S, Teti A (2006) Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 43:315\u2013325","journal-title":"J Med Genet"},{"key":"1272_CR29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0037-1619909","volume":"18","author":"M Helfrich","year":"2009","unstructured":"Helfrich M, Perdu B, Coxon F (2009) Human recessive osteopetrosis. New understanding of osteoclast function through molecular and functional analysis of a rare genetic bone disease. Osteologie 18:260\u2013267","journal-title":"Osteologie"},{"key":"1272_CR30","doi-asserted-by":"crossref","first-page":"E1071","DOI":"10.1002\/humu.21167","volume":"31","author":"A Pangrazio","year":"2010","unstructured":"Pangrazio A, Pusch M, Caldana E, Frattini A, Lanino E, Tamhankar PM, Phadke S, Lopez AG, Orchard P, Mihci E, Abinun M, Wright M, Vettenranta K, Bariae I, Melis D, Tezcan I, Baumann C, Locatelli F, Zecca M, Horwitz E, Mansour LS, Van RM, Vezzoni P, Villa A, Sobacchi C (2010) Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations. Hum Mutat 31:E1071\u2013E1080","journal-title":"Hum Mutat"},{"key":"1272_CR31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","volume":"83","author":"MM Guerrini","year":"2008","unstructured":"Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, Coxon FP, Helfrich MH, Crockett JC, Mellis D, Vellodi A, Tezcan I, Notarangelo LD, Rogers MJ, Vezzoni P, Villa A, Frattini A (2008) Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 83:64\u201376","journal-title":"Am J Hum Genet"},{"key":"1272_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pcl.2009.11.006","volume":"57","author":"CG Steward","year":"2010","unstructured":"Steward CG (2010) Hematopoietic Stem Cell Transplantation for Osteopetrosis. Pediatr Clin N Am 57:171\u2013180","journal-title":"Pediatr Clin N Am"},{"key":"1272_CR33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","volume":"39","author":"C Sobacchi","year":"2007","unstructured":"Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del FA, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH (2007) Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 39:960\u2013962","journal-title":"Nat Genet"},{"key":"1272_CR34","first-page":"337","volume":"24","author":"HJ Knowles","year":"2009","unstructured":"Knowles HJ, Athanasou NA (2009) Canonical and non-canonical pathways of osteoclast formation. Histol Histopathol 24:337\u2013346","journal-title":"Histol Histopathol"},{"key":"1272_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S8756-3282(00)00333-1","volume":"27","author":"RD Tiegs","year":"2000","unstructured":"Tiegs RD, Lohse CM, Wollan PC, Melton LJ (2000) Long-term trends in the incidence of Paget's disease of bone. Bone 27:423\u2013427","journal-title":"Bone"},{"key":"1272_CR36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/rheumatology\/kep212","volume":"48","author":"S Bastin","year":"2009","unstructured":"Bastin S, Bird H, Gamble G, Cundy T (2009) Paget's disease of bone\u2013becoming a rarity? Rheumatology (Oxford) 48:1232\u20131235","journal-title":"Rheumatology (Oxford)"},{"key":"1272_CR37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S8756-3282(02)00817-7","volume":"31","author":"P Selby","year":"2002","unstructured":"Selby P, Davie M, Ralston S, Stone M (2002) Guidelines on the management of Paget's disease of bone. Bone 31:366\u2013373","journal-title":"Bone"},{"key":"1272_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(08)61035-1","volume":"372","author":"SH Ralston","year":"2008","unstructured":"Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget's disease of bone. Lancet 372:155\u2013163","journal-title":"Lancet"},{"key":"1272_CR39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1359\/jbmr.061108","volume":"22","author":"D Naot","year":"2007","unstructured":"Naot D, Bava U, Matthews B, Callon KE, Gamble GD, Black M, Song S, Pitto RP, Cundy T, Cornish J, Reid IR (2007) Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res 22:298\u2013309","journal-title":"J Bone Miner Res"},{"key":"1272_CR40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.abb.2008.02.045","volume":"473","author":"MH Helfrich","year":"2008","unstructured":"Helfrich MH, Hocking LJ (2008) Genetics and aetiology of Pagetic diseases of bone. Arch Biochem Biophys 473:172\u2013182","journal-title":"Arch Biochem Biophys"},{"key":"1272_CR41","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1359\/jbmr.2000.15.12.2315","volume":"15","author":"MH Helfrich","year":"2000","unstructured":"Helfrich MH, Hobson RP, Grabowski PS, Zurbriggen A, Cosby SL, Dickson GR, Fraser WD, Ooi CG, Selby PL, Crisp AJ, Wallace RG, Kahn S, Ralston SH (2000) A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res 15:2315\u20132329","journal-title":"J Bone Miner Res"},{"key":"1272_CR42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1359\/JBMR.041205","volume":"20","author":"JR Cavey","year":"2005","unstructured":"Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B, Searle MS, Layfield R (2005) Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J Bone Miner Res 20:619\u2013624","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"1272_CR43","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2091-8-S1-S5","volume":"8","author":"R Layfield","year":"2007","unstructured":"Layfield R, Shaw B (2007) Ubiquitin-mediated signalling and Paget's disease of bone. BMC Biochem 8(Suppl 1):S5","journal-title":"BMC Biochem"},{"key":"1272_CR44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","volume":"347","author":"MP Whyte","year":"2002","unstructured":"Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S (2002) Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 347:175\u2013184","journal-title":"N Engl J Med"},{"key":"1272_CR45","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","volume":"11","author":"T Cundy","year":"2002","unstructured":"Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J (2002) A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 11:2119\u20132127","journal-title":"Hum Mol Genet"},{"key":"1272_CR46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.berh.2007.11.005","volume":"22","author":"SH Ralston","year":"2008","unstructured":"Ralston SH (2008) Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders. Best Pract Res Clin Rheumatol 22:101\u2013111","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1272_CR47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00774-004-0518-y","volume":"22","author":"S Takata","year":"2004","unstructured":"Takata S, Yasui N, Nakatsuka K, Ralston SH (2004) Evolution of understanding of genetics of Paget's disease of bone and related diseases. J Bone Miner Metab 22:519\u2013523","journal-title":"J Bone Miner Metab"},{"key":"1272_CR48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","volume":"24","author":"AE Hughes","year":"2000","unstructured":"Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, Van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24:45\u201348","journal-title":"Nat Genet"},{"key":"1272_CR49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1359\/jbmr.2002.17.1.26","volume":"17","author":"MP Whyte","year":"2002","unstructured":"Whyte MP, Hughes AE (2002) Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 17:26\u201329","journal-title":"J Bone Miner Res"},{"key":"1272_CR50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1359\/jbmr.2003.18.8.1381","volume":"18","author":"K Nakatsuka","year":"2003","unstructured":"Nakatsuka K, Nishizawa Y, Ralston SH (2003) Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 18:1381\u20131385","journal-title":"J Bone Miner Res"},{"key":"1272_CR51","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/aps.2009.90","volume":"30","author":"YH Ke","year":"2009","unstructured":"Ke YH, Yue H, He JW, Liu YJ, Zhang ZL (2009) Early onset Paget's disease of bone caused by a novel mutation (78dup27) of the TNFRSF11A gene in a Chinese family. Acta Pharmacol Sin 30:1204\u20131210","journal-title":"Acta Pharmacol Sin"},{"issue":"Suppl. 1","key":"1272_CR52","first-page":"s34","volume":"80","author":"OME Albagha","year":"2007","unstructured":"Albagha OME, Rojas J, van 't Hof R, Dorin J, Ralston SH (2007) A mouse model of early onset Paget's disease of bone caused by an insertion mutation affecting the RANK signal peptide. Calcif Tissue Int 80(suppl 1):s34","journal-title":"Calcif Tissue Int"},{"key":"1272_CR53","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","volume":"3","author":"V Iotsova","year":"1997","unstructured":"Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285\u20131289","journal-title":"Nat Med"},{"key":"1272_CR54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","volume":"13","author":"MA Lomaga","year":"1999","unstructured":"Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, der HA van, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13:1015\u201324","journal-title":"Genes Dev"},{"key":"1272_CR55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1534-5807(03)00403-9","volume":"6","author":"A Duran","year":"2004","unstructured":"Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J, Diaz-Meco MT (2004) The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 6:303\u2013309","journal-title":"Dev Cell"},{"key":"1272_CR56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","volume":"4","author":"A Naito","year":"1999","unstructured":"Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353\u2013362","journal-title":"Genes Cells"},{"key":"1272_CR57","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/hmg\/11.22.2735","volume":"11","author":"LJ Hocking","year":"2002","unstructured":"Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH (2002) Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11:2735\u20132739","journal-title":"Hum Mol Genet"},{"key":"1272_CR58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","volume":"27","author":"R Doffinger","year":"2001","unstructured":"Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le DF, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israel A, Courtois G, Casanova JL (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27:277\u2013285","journal-title":"Nat Genet"},{"key":"1272_CR59","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","volume":"274","author":"L Lum","year":"1999","unstructured":"Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274:13613\u201313618","journal-title":"J Biol Chem"},{"key":"1272_CR60","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10585-009-9279-2","volume":"26","author":"KC Nannuru","year":"2009","unstructured":"Nannuru KC, Futakuchi M, Sadanandam A, Wilson TJ, Varney ML, Myers KJ, Li X, Marcusson EG, Singh RK (2009) Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis. Clin Exp Metastasis 26:797\u2013808","journal-title":"Clin Exp Metastasis"},{"key":"1272_CR61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","volume":"7","author":"CC Lynch","year":"2005","unstructured":"Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M (2005) MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7:485\u2013496","journal-title":"Cancer Cell"},{"key":"1272_CR62","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI13890","volume":"108","author":"J Lam","year":"2001","unstructured":"Lam J, Nelson CA, Ross FP, Teitelbaum SL, Fremont DH (2001) Crystal structure of the TRANCE\/RANKL cytokine reveals determinants of receptor-ligand specificity. J Clin Invest 108:971\u2013979","journal-title":"J Clin Invest"},{"key":"1272_CR63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2007.03.005","volume":"37","author":"FK Chan","year":"2007","unstructured":"Chan FK (2007) Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 37:101\u2013107","journal-title":"Cytokine"},{"key":"1272_CR64","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412\u20132424","journal-title":"Genes Dev"},{"key":"1272_CR65","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"key":"1272_CR66","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1074\/jbc.M601553200","volume":"281","author":"C Bossen","year":"2006","unstructured":"Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, Ambrose C, Tschopp J, Schneider P (2006) Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem 281:13964\u201313971","journal-title":"J Biol Chem"},{"key":"1272_CR67","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","volume":"288","author":"FK Chan","year":"2000","unstructured":"Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288:2351\u20132354","journal-title":"Science"},{"key":"1272_CR68","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1359\/JBMR.050706","volume":"20","author":"K Kanazawa","year":"2005","unstructured":"Kanazawa K, Kudo A (2005) Self-assembled RANK induces osteoclastogenesis ligand-independently. J Bone Miner Res 20:2053\u20132060","journal-title":"J Bone Miner Res"},{"key":"1272_CR69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.molcel.2009.01.014","volume":"33","author":"ZJ Chen","year":"2009","unstructured":"Chen ZJ, Sun LJ (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33:275\u2013286","journal-title":"Mol Cell"},{"key":"1272_CR70","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1074\/jbc.274.12.7724","volume":"274","author":"BG Darnay","year":"1999","unstructured":"Darnay BG, Ni J, Moore PA, Aggarwal BB (1999) Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J Biol Chem 274:7724\u20137731","journal-title":"J Biol Chem"},{"key":"1272_CR71","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344\u2013362","journal-title":"Cell"},{"key":"1272_CR72","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbrc.2007.06.017","volume":"359","author":"B Lamothe","year":"2007","unstructured":"Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG (2007) TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun 359:1044\u20131049","journal-title":"Biochem Biophys Res Commun"},{"key":"1272_CR73","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","volume":"22","author":"J Mizukami","year":"2002","unstructured":"Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K, Sakurai N (2002) Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase complex through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol 22:992\u20131000","journal-title":"Mol Cell Biol"},{"key":"1272_CR74","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1074\/jbc.M608867200","volume":"282","author":"A Besse","year":"2007","unstructured":"Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin SC, Wu H, Darnay BG (2007) TAK1-dependent signaling requires functional interaction with TAB2\/TAB3. J Biol Chem 282:3918\u20133928","journal-title":"J Biol Chem"},{"key":"1272_CR75","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncb1384","volume":"8","author":"CJ Wu","year":"2006","unstructured":"Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8:398\u2013406","journal-title":"Nat Cell Biol"},{"key":"1272_CR76","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncb0805-758","volume":"7","author":"ZJ Chen","year":"2005","unstructured":"Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7:758\u2013765","journal-title":"Nat Cell Biol"},{"key":"1272_CR77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.0105-2896.2005.00335.x","volume":"208","author":"WC Horne","year":"2005","unstructured":"Horne WC, Sanjay A, Bruzzaniti A, Baron R (2005) The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev 208:106\u2013125","journal-title":"Immunol Rev"},{"key":"1272_CR78","doi-asserted-by":"crossref","first-page":"30011","DOI":"10.1074\/jbc.M100414200","volume":"276","author":"JR Arron","year":"2001","unstructured":"Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H, Choi Y (2001) A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J Biol Chem 276:30011\u201330017","journal-title":"J Biol Chem"},{"key":"1272_CR79","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1359\/jbmr.090205","volume":"24","author":"A Nakajima","year":"2009","unstructured":"Nakajima A, Sanjay A, Chiusaroli R, Adapala NS, Neff L, Itzsteink C, Horne WC, Baron R (2009) Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J Bone Miner Res 24:1162\u20131172","journal-title":"J Bone Miner Res"},{"key":"1272_CR80","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729\u2013733","journal-title":"Nature"},{"key":"1272_CR81","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2009-04-215020","volume":"114","author":"M Hiasa","year":"2009","unstructured":"Hiasa M, Abe M, Nakano A, Oda A, Amou H, Kido S, Takeuchi K, Kagawa K, Yata K, Hashimoto T, Ozaki S, Asaoka K, Tanaka E, Moriyama K, Matsumoto T (2009) GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood 114:4517\u20134526","journal-title":"Blood"},{"key":"1272_CR82","doi-asserted-by":"crossref","unstructured":"Hakozaki A, Yoda M, Tohmonda T, Furukawa M, Hikata T, Uchikawa S, Takaishi H, Matsumoto M, Chiba K, Horiuchi K, Toyama Y (2010) Receptor Activator of NF-{kappa}B Ligand Induces Ectodomain Shedding of Receptor Activator of NF-{kappa}B in Murine RAW264.7 Macrophages. J Immunol","DOI":"10.4049\/jimmunol.0901188"},{"key":"1272_CR83","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1074\/jbc.M510383200","volume":"281","author":"D Xu","year":"2006","unstructured":"Xu D, Wang S, Liu W, Liu J, Feng X (2006) A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage. J Biol Chem 281:4678\u20134690","journal-title":"J Biol Chem"},{"key":"1272_CR84","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmed.2006.05.005","volume":"12","author":"HA Kuzmiak","year":"2006","unstructured":"Kuzmiak HA, Maquat LE (2006) Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 12:306\u2013316","journal-title":"Trends Mol Med"},{"issue":"Suppl. 1","key":"1272_CR85","first-page":"S103","volume":"21","author":"JC Crockett","year":"2006","unstructured":"Crockett JC, Helfrich M, Duthie A, Scott D, Greenhorn J, Ralston S, Rogers MJ (2006) Mutations in the RANK signal peptide alter the subcellular localisation of RANK and prevent ligand-dependent activation of NFkappa B. J Bone Miner Res 21(suppl 1):S103","journal-title":"J Bone Miner Res"},{"key":"1272_CR86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1083\/jcb.200306020","volume":"163","author":"EL Snapp","year":"2003","unstructured":"Snapp EL, Hegde RS, Francolini M, Lombardo F, Colombo S, Pedrazzini E, Borgese N, Lippincott-Schwartz J (2003) Formation of stacked ER cisternae by low affinity protein interactions. J Cell Biol 163:257\u2013269","journal-title":"J Cell Biol"},{"key":"1272_CR87","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nrm2546","volume":"9","author":"SS Vembar","year":"2008","unstructured":"Vembar SS, Brodsky JL (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9:944\u2013957","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1272_CR88","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.1999.79.3.683","volume":"79","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol Rev 79:683\u2013701","journal-title":"Physiol Rev"},{"key":"1272_CR89","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T (2007) p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131\u201324145","journal-title":"J Biol Chem"},{"key":"1272_CR90","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng1332","volume":"36","author":"GD Watts","year":"2004","unstructured":"Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377\u2013381","journal-title":"Nat Genet"},{"key":"1272_CR91","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200908115","volume":"187","author":"JS Ju","year":"2009","unstructured":"Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 187:875\u2013888","journal-title":"J Cell Biol"},{"key":"1272_CR92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/path.2094","volume":"211","author":"A Terman","year":"2007","unstructured":"Terman A, Gustafsson B, Brunk UT (2007) Autophagy, organelles and ageing. J Pathol 211:134\u2013143","journal-title":"J Pathol"},{"issue":"Suppl","key":"1272_CR93","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1016\/j.bone.2009.03.620","volume":"44","author":"EA Azzam","year":"2009","unstructured":"Azzam EA, Scott DI, Gregory JS, McKinnon AD, Helfrich MH (2009) Expresssion of inclusion body-associated proteins in Paget's disease of bone. Bone 44(Suppl):S326\u2013S327","journal-title":"Bone"},{"key":"1272_CR94","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1371\/journal.pbio.0040423","volume":"4","author":"S Bernales","year":"2006","unstructured":"Bernales S, McDonald KL, Walter P (2006) Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 4:e423","journal-title":"PLoS Biol"},{"key":"1272_CR95","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1359\/jbmr.081105","volume":"24","author":"A Merchant","year":"2009","unstructured":"Merchant A, Smielewska M, Patel N, Akunowicz JD, Saria EA, Delaney JD, Leach RJ, Seton M, Hansen MF (2009) Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone. J Bone Miner Res 24:484\u2013494","journal-title":"J Bone Miner Res"},{"key":"1272_CR96","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jc.2008-1140","volume":"94","author":"BG Matthews","year":"2009","unstructured":"Matthews BG, Naot D, Bava U, Callon KE, Pitto RP, McCowan SA, Wattie D, Cundy T, Cornish J, Reid IR (2009) Absence of somatic SQSTM1 mutations in Paget's disease of bone. J Clin Endocrinol Metab 94:691\u2013694","journal-title":"J Clin Endocrinol Metab"},{"key":"1272_CR97","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1172\/JCI24281","volume":"115","author":"GD Roodman","year":"2005","unstructured":"Roodman GD, Windle JJ (2005) Paget disease of bone. J Clin Invest 115:200\u2013208","journal-title":"J Clin Invest"},{"key":"1272_CR98","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1359\/JBMR.051108","volume":"21","author":"N Kurihara","year":"2006","unstructured":"Kurihara N, Zhou H, Reddy SV, Garcia PV, Subler MA, Dempster DW, Windle JJ, Roodman GD (2006) Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res 21:446\u2013455","journal-title":"J Bone Miner Res"},{"key":"1272_CR99","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/jc.2007-1978","volume":"93","author":"BG Matthews","year":"2008","unstructured":"Matthews BG, Afzal MA, Minor PD, Bava U, Callon KE, Pitto RP, Cundy T, Cornish J, Reid IR, Naot D (2008) Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease. J Clin Endocrinol Metab 93:1398\u20131401","journal-title":"J Clin Endocrinol Metab"},{"key":"1272_CR100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1302\/0301-620X.70B2.3346299","volume":"70-B","author":"PH Osterberg","year":"1988","unstructured":"Osterberg PH, Wallace RGH, Adams DA, Crone RS, Dickson GR, Kanis JA, Mollan RAB, Nevin NC, Sloan J, Toner PG (1988) Familial expansile osteolysis:a new dysplasia. J Bone Joint Surg 70-B:255\u2013260","journal-title":"J Bone Joint Surg"},{"key":"1272_CR101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005792-200203000-00002","volume":"81","author":"MP Whyte","year":"2002","unstructured":"Whyte MP, Reinus WR, Podgornik MN, Mills BG (2002) Familial expansile osteolysis (excessive RANK effect) in a 5-generation American kindred. Medicine (Baltimore) 81:101\u2013121","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 1","key":"1272_CR102","first-page":"S34","volume":"82","author":"A Daroszewska","year":"2008","unstructured":"Daroszewska A, Rojas J, Rose L, van 't Hof RJ, Ralston SH (2008) Knock-in of the P392L mutation of SQSTM1 causes a phenotype similar to Paget's disease in mice. Calcif Tissue Int 82(suppl 1):S34\u2013S35","journal-title":"Calcif Tissue Int"},{"issue":"Suppl","key":"1272_CR103","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/j.bone.2009.03.116","volume":"44","author":"A Daroszewska","year":"2009","unstructured":"Daroszewska A, Rose L, Rose K, Sedlmeier R, van 't Hof RJ, Ralston SH (2009) Development of a novel animal model for the syndrome of inclusions body myopathy, Paget's disease and fronto-temporal dementia. Bone 44(Suppl):S247","journal-title":"Bone"},{"key":"1272_CR104","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-151-8-200910200-00006","volume":"151","author":"JB Richards","year":"2009","unstructured":"Richards JB, Kavvoura FK, Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, Zillikens MC, Wilson SG, Mullin BH, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra BA, Pols HA, Sigurdsson G, Thorsteinsdottir U, Soranzo N, Williams FM, Zhou Y, Ralston SH, Thorleifsson G, van Duijn CM, Kiel DP, Stefansson K, Uitterlinden AG, Ioannidis JP, Spector TD (2009) Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 151:528\u2013537","journal-title":"Ann Intern Med"},{"key":"1272_CR105","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ng.446","volume":"41","author":"F Rivadeneira","year":"2009","unstructured":"Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, Richards JB, Zillikens MC, Kavvoura FK, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Grundberg E, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra B, Pastinen T, Pols HA, Sigurdsson G, Soranzo N, Thorleifsson G, Thorsteinsdottir U, Williams FM, Wilson SG, Zhou Y, Ralston SH, van Duijn CM, Spector T, Kiel DP, Stefansson K, Ioannidis JP, Uitterlinden AG (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199\u20131206","journal-title":"Nat Genet"},{"key":"1272_CR106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","volume":"26","author":"JC Scimeca","year":"2000","unstructured":"Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF (2000) The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants. Bone 26:207\u2013213","journal-title":"Bone"},{"key":"1272_CR107","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","volume":"25","author":"A Frattini","year":"2000","unstructured":"Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A (2000) Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25:343\u2013346","journal-title":"Nat Genet"},{"key":"1272_CR108","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/9.13.2059","volume":"9","author":"U Kornak","year":"2000","unstructured":"Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C (2000) Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 9:2059\u20132063","journal-title":"Hum Mol Genet"},{"key":"1272_CR109","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","volume":"23","author":"YP Li","year":"1999","unstructured":"Li YP, Chen W, Liang Y, Li E, Stashenko P (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447\u2013451","journal-title":"Nat Genet"},{"key":"1272_CR110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm842","volume":"9","author":"N Chalhoub","year":"2003","unstructured":"Chalhoub N, Benachenhou N, Rajapurohitam V, Pata M, Ferron M, Frattini A, Villa A, Vacher J (2003) Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 9:399\u2013406","journal-title":"Nat Med"},{"key":"1272_CR111","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S8756-3282(01)00416-1","volume":"28","author":"V Rajapurohitam","year":"2001","unstructured":"Rajapurohitam V, Chalhoub N, Benachenhou N, Neff L, Baron R, Vacher J (2001) The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation\/function. Bone 28:513\u2013523","journal-title":"Bone"},{"key":"1272_CR112","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI30328","volume":"117","author":"L Wesenbeeck Van","year":"2007","unstructured":"Van Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van HE, Timmermans JP, Vanhoenacker F, Jacobs R, Peruzzi B, Teti A, Helfrich MH, Rogers MJ, Villa A, Van HW (2007) Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest 117:919\u2013930","journal-title":"J Clin Invest"},{"key":"1272_CR113","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1359\/jbmr.071107","volume":"23","author":"A Fattore Del","year":"2008","unstructured":"Del Fattore A, Fornari R, Van WL, de FF T, JP PB, Cappariello A, Rucci N, Spera G, Helfrich MH, Van HW, Migliaccio S, Teti A (2008) A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts. J Bone Miner Res 23:380\u2013391","journal-title":"J Bone Miner Res"},{"key":"1272_CR114","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/excr.1999.4585","volume":"251","author":"FP Reinholt","year":"1999","unstructured":"Reinholt FP, Hultenby K, Heineg\u00e5rd D, Marks SC Jr, Norgard M, Anderson G (1999) Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia\/ia) rats: implications for secretory function. Exp Cell Res 251:477\u2013491","journal-title":"Exp Cell Res"},{"key":"1272_CR115","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1542\/peds.109.6.e97","volume":"109","author":"S Dupuis-Girod","year":"2002","unstructured":"Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet JC, Faivre L, Le DF, Durand P, Doffinger R, Smahi A, Israel A, Courtois G, Brousse N, Blanche S, Munnich A, Fischer A, Casanova JL, Bodemer C (2002) Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109:e97","journal-title":"Pediatrics"},{"key":"1272_CR116","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1101\/gad.14.7.854","volume":"14","author":"D Rudolph","year":"2000","unstructured":"Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, Elia AJ, Mak TW (2000) Severe liver degeneration and lack of NF-kappaB activation in NEMO\/IKKgamma-deficient mice. Genes Dev 14:854\u2013862","journal-title":"Genes Dev"},{"key":"1272_CR117","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.80.9.2752","volume":"80","author":"WS Sly","year":"1983","unstructured":"Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE (1983) Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80:2752\u20132756","journal-title":"Proc Natl Acad Sci USA"},{"key":"1272_CR118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00223-007-9098-x","volume":"82","author":"DS Margolis","year":"2008","unstructured":"Margolis DS, Szivek JA, Lai LW, Lien YH (2008) Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice. Calcif Tissue Int 82:66\u201376","journal-title":"Calcif Tissue Int"},{"key":"1272_CR119","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddm037","volume":"16","author":"CC Weihl","year":"2007","unstructured":"Weihl CC, Miller SE, Hanson PI, Pestronk A (2007) Transgenic expression of inclusion body myopathy associated mutant p97\/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum Mol Genet 16:919\u2013928","journal-title":"Hum Mol Genet"},{"key":"1272_CR120","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/340731","volume":"70","author":"N Laurin","year":"2002","unstructured":"Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/p62) in Paget disease of bone. Am J Hum Genet 70:1582\u20131588","journal-title":"Am J Hum Genet"},{"key":"1272_CR121","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1172\/JCI28267","volume":"117","author":"N Kurihara","year":"2007","unstructured":"Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR, Reddy SV, Gruber HE, Windle JJ, Roodman GD (2007) Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest 117:133\u2013142","journal-title":"J Clin Invest"},{"key":"1272_CR122","doi-asserted-by":"crossref","unstructured":"Langston AL, Campbell MK, Fraser WD, Maclennan GS, Selby PL, Ralston SH (2009) Randomised Trial of Intensive Bisphosphonate Treatment Versus Symptomatic Management in Paget's Disease of Bone. J Bone Miner Res","DOI":"10.1359\/jbmr.090709"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1272-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1272-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1272-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:28:18Z","timestamp":1685590098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1272-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1272-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}